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Abstract: BACKGROUND: The unmonitored use of complementary medicine in patients with cancer
can be associated with an increased risk of safety-related issues, such as lower adherence to conventional
cancer therapies. Training oncology physicians to advise their patients about the effectiveness and safety
of these therapies could improve this situation. METHODS: The objective of this study was to develop
and pretest a consultation framework that has high potential to be widely implemented. The framework
comprises: 1) a systematically developed and tested, manualized, guided consultation; and 2) blended
learning training (e-learning and communication skills training workshop) to upskill oncology physicians
in advising their patients on complementary and integrative medicine (CIM). For this implementation
study, mixed methods were used to develop the manual (literature review, consensus procedure, pilot
testing) and the training (questionnaires and interviews with oncology physicians and patients with can-
cer and an examination of the skills in a setting with standardized patients). RESULTS: The training
was tested with 47 oncology physicians from across Germany. The manual-guided consultation (con-
text: general information on the setting and communication techniques; inform: consultation duration
and content; capture: previous CIM use; prioritize: focus on consultation; advise: evidence-based CIM
recommendations; discuss, advise, accept, or advise against other CIM; concretize advice: summary and
implementation; and monitor: documentation) was considered suitable. The structure and time frame
(maximum, 20 minutes) of the consultation as well as the training were feasible and well accepted. CON-
CLUSIONS: The current study demonstrates that the KOKON-KTO framework (a German acronym
for Competence Network for Complementary Medicine - Consultation Training for Oncology Physicians)
is suitable for training oncology physicians. Its implementation can lead to better physician-patient
communication about CIM in cancer.
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BACKGROUND: The unmonitored use of complementary medicine in patients with cancer can be associated with an increased risk of 
safety-related issues, such as lower adherence to conventional cancer therapies. Training oncology physicians to advise their patients 
about the effectiveness and safety of these therapies could improve this situation. METHODS: The objective of this study was to develop 
and pretest a consultation framework that has high potential to be widely implemented. The framework comprises: 1) a systematically 
developed and tested, manualized, guided consultation; and 2) blended learning training (e-learning and communication skills training 
workshop) to upskill oncology physicians in advising their patients on complementary and integrative medicine (CIM). For this imple-
mentation study, mixed methods were used to develop the manual (literature review, consensus procedure, pilot testing) and the training 
(questionnaires and interviews with oncology physicians and patients with cancer and an examination of the skills in a setting with stand-
ardized patients). RESULTS: The training was tested with 47 oncology physicians from across Germany. The manual-guided consulta-
tion (context: general information on the setting and communication techniques; inform: consultation duration and content; capture: 
previous CIM use; prioritize: focus on consultation; advise: evidence-based CIM recommendations; discuss, advise, accept, or advise 
against other CIM; concretize advice: summary and implementation; and monitor: documentation) was considered suitable. The struc-
ture and time frame (maximum, 20 minutes) of the consultation as well as the training were feasible and well accepted. CONCLUSIONS: 
The current study demonstrates that the KOKON-KTO framework (a German acronym for Competence Network for Complementary 
Medicine - Consultation Training for Oncology Physicians) is suitable for training oncology physicians. Its implementation can lead to 
better physician-patient communication about CIM in cancer. Cancer 2020;126:3031-3041. © 2020 The Authors. Cancer published by 
Wiley Periodicals, Inc. on behalf of American Cancer Society This is an open access article under the terms of the Creative Commons 
Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly 
cited, the use is non-commercial and no modifications or adaptations are made. 
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INTRODUCTION
Many patients with cancer use complementary medicine (CM). A systematic review has demonstrated that the use of CM 
has increased over time, and approximately one-half of patients with cancer have used it at least once.1 Patients who have 
cancer consider CM therapies for various reasons, including the wish to reduce the side effects of cancer treatment or to 
gain personal control over their own treatment plan.2-4 A retrospective analysis of data from a US cancer registry5 con-
cluded that the use of these therapies administered by nonmedical personnel in an alternative context was associated with 
a 2-fold greater risk of death compared with nouse. This was mainly explained by lower adherence to the recommended 
cancer treatments. This finding, which is also supported by previous research,6,7 highlights the importance of discussing 
CM during oncology consultations. Because alternative medicine usually refers to therapies that are used as an alternative 
to conventional cancer treatment in an unmonitored context, it is important to support patients in translating their needs 
and wishes into a complementary and integrative model of care to reduce possible safety-related risk issues.
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Oncology physicians are members of the cancer 
care team and often are in early contact with the 
patients. Data show that patients want to be informed 
by their oncology physicians about complementary and 
integrative medicine  (CIM)8,9, and addressing CIM 
might increase patients’ trust in cancer treatments.10,11 
Moreover, studies show that physician-led consulta-
tions on CIM might have a positive effect on adher-
ence to cancer treatments and overall quality of life in 
patients with cancer.12,13 However, physicians often do 
not initiate CIM consultations because of low CIM 
knowledge.14 There is an urgent need for oncology 
physicians to feel competent in guiding their patients 
through the often confusing and heterogeneous field 
of CIM.15 Guidelines for CIM consultations in oncol-
ogy exist,7 but consultations based on those guidelines 
are often difficult to implement for reasons such as a 
lack of time or the absence of previous evidence-based 
CIM training.7,16 Surveys among physicians indicate a 
strong interest in evidence-based CIM training for can-
cer care.17-20 In most countries, training in some type 
of CIM therapy is available for physicians but consists 
of training on how to provide CIM (eg, acupuncture or 
phytotherapy) and not how to advise on available CIM 
therapies.
With the goal of translating evidence-based knowl-
edge into clinical practice, implementation science 
 addresses these issues by translating scientific findings into 
practical application.21 Our previous cluster-randomized 
study showed that oncology physicians who had little 
experience in discussing CIM gained the most benefit 
from CIM training.22 However, this training used the 
conceptual approach that patients would receive CIM 
information from an oncology physician who was not 
their cancer-treating physician. This resulted in consul-
tations lasting on average 45 minutes, making broad im-
plementation difficult. To meet the needs of patients and 
physicians and to foster uptake in usual care, training and 
CIM consultation must fit into the standard cancer care 
continuum. Hence, it is crucial for the implementation 
strategy to guide the development of the consultation 
framework.
In this article, we describe the implementa-
tion strategy, the development of the KOKON-KTO 
(a German acronym for Competence Network for 
Complementary Medicine - Consultation Training for 
Oncology Physicians) framework and the  associated 
consultation manual, the corresponding blended learn-
ing, and a pilot test of the training and its impact on 
physician-patient interactions.
Ethics Approval and Consent to Participate
The following independent Medical Ethics committees 
approved the KOKON-KTO study: Ethics Committee of 
the Charité - Universitätsmedizin Berlin (EA1/127/17), 
Medical Association Hamburg (MC-368/17), Medical 
Association Baden-Wuerttemberg (B-F-2017-10), 
Medical Association Nord Rhine (2417337), Ethics 
Committee of the Medical Association of Westphalia-
Lippe (2017-624-b-S), Ethics Committee at the Medical 
Faculty of Wurzburg (274/17_z-me), Ethics Committee 
of the Medical Faculty of Heidelberg (S-550/2017), and 
Ethics Commission of the Albert-Ludwigs-University 
of Freiburg (531/17). Informed consent was obtained 
from all participants. The trial registration number of 
the KOKON-KTO study is DRKS00012704 on the 
German Clinical Trials Register (registered August 28, 
2017).
Availability of Data and Materials
The data sets analyzed during the current study are availa-
ble from the corresponding author on reasonable request.
MATERIALS AND METHODS
Implementation Strategy
The implementation strategy included the following 
criteria, which were considered crucial for the future 
dissemination of the framework (manual and train-
ing): 1) clinically feasible consultation time that can be 
implemented in usual care (maximal length of 20 min-
utes), 2) low threshold for training access (time length, 
date, location flexibility), 3) teaching of transferable 
skills that are perceived as useful for other consulta-
tion situations, 4) a consultation framework that allows 
adaptation to the individual consultation style and in-
cludes a structured manual and clinical practice materi-
als, and 5) compatibility with relevant standards (eg, 
competency framework). The implementation strategy 
was based on the RE-AIM framework (a model for 
evaluating public health interventions that assesses 5 
dimensions: reach, efficacy, adoption, implementation, 
and maintenance).23
Development of the KOKON-KTO Framework
The KOKON-KTO framework was developed for 
oncology physicians’ consultations to help to close the 
gap: patients want to receive CIM advice from their 
oncology physician, but physicians do not feel competent 
to provide it. The objective of the KOKON-KTO is to 
enable oncology physicians to provide advice to their can-
cer patients about the effectiveness and safety of CIM in 
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a nonjudgmental and empathic consultation. The frame-
work might be adaptable to other health professions in 
the cancer care team (eg, nurses), but is not intended to 
train Integrative Medicine Physicians providing CIM. 
Therefore, the KOKON-KTO framework was developed 
for its use by oncology physicians working in private prac-
tices or cancer clinics to enhance physician-patient com-
munication about CIM as an addition to standard cancer 
care.
As described in previous medical education initia-
tives,24,25 training oncology physicians in CIM might 
increase communication skills, improve the oncology 
physician-patient interaction, and enhance physicians’ 
understanding of CIM use in patients with cancer. 
Taking this knowledge into account, the objective 
of the KOKON-KTO framework, consisting of the 
KOKON-KTO manual and the blended learning train-
ing (e-learning and workshop), is to follow a systematic 
and evidence-based approach toward teaching oncology 
physicians how to provide CIM advice to their patients 
with cancer to enhance patients’ and physicians’ dis-
cussions of CIM as a supportive option during cancer 
treatment.
KOKON-KTO consultation manual
Development of the manual was based on a systematic 
literature search and analysis, followed by an interna-
tional expert consensus procedure (Fig. 1). The manual 
Figure 1. This is a flowchart of the development and evaluation process. Asterisks indicate complementary and integrative medicine 
(CIM). KOKON-KTO indicates Competence Network for Complementary Medicine - Consultation Training for Oncology Physicians.
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was then pilot tested in clinical practice. At each step, the 
implementation strategy described above was reflected 
upon and guided the decisions. The expert panel con-
sisted of 9 individuals with knowledge in integrative on-
cology, communication, psychology, psycho-oncology, 
oncology, medical ethics, public health, and epidemi-
ology. The literature search was conducted using the 
MEDLINE, CENTRAL, EMBASE, and Web of Science 
databases to identify suitable publications. On the basis of 
the literature analysis, a draft of the KOKON-KTO con-
sultation manual was developed and discussed with the 
expert panel (first consensus round). Before the second 
consensus round, 1 patient representative and 23 oncol-
ogy physicians were invited to complete an online survey 
(SoSci Survey26 software) with 13 items on the structure 
and content of the manual (see Supporting Table 1). To 
determine acceptability, 1 physician (C.M.W.) with ex-
perience in CIM consultations conducted face-to-face 
interviews with 3 patients following a semistructured 
interview guideline (see Supporting Table 2). The results 
were discussed with the expert panel, and the manual was 
revised and finalized (third consensus round). In the sub-
sequent pilot phase (November and December 2017), 
3 oncology physicians with CIM expertise used the 
KOKON-KTO consultation manual in consultations 
with their patients and were interviewed by 1 interviewer 
(S.M.H.) following semistructured interview guidelines 
about their practical experience (see Supporting Table 3). 
The interview results were shared with the expert panel, 
and the manual was refined accordingly.
KOKON-KTO training
The learning objectives for the KOKON-KTO training 
followed the Bloom taxonomy27 and were in line with 
the core set of educational competencies for integrative 
oncology that was developed in an international and 
interprofessional consensus procedure by the Society of 
Integrative Oncology.28 Blended learning was adopted, 
in which we combined e-learning modules on the pro-
vider platform Moodlerooms/Open LMS29 with a 2-day, 
on-site skills training workshop. The overall learning ob-
jective is as follows: after the KOKON-KTO training, 
oncology physicians should be able to compare different 
CIM therapies and other supportive therapies and to lead 
a context-adapted KOKON-KTO consultation. The spe-
cific learning objectives are: 1) after the e-learning session, 
oncology physicians should be able to a) classify the needs 
for and challenges of CIM in oncology, b) differentiate be-
tween various CIM therapies and other supportive thera-
pies, and c) apply essential elements of a KOKON-KTO 
consultation in case studies; and 2) after the on-site skills 
training workshop, oncology physicians should be able 
to a) apply knowledge about CIM therapies  and other 
supportive therapies to specific situations, b) implement 
elements of a KOKON-KTO conversation in role-play 
exercises, c) deal practically with the challenges of CIM 
therapies and other supportive therapies in consultations, 
and d) conduct a KOKON-KTO consultation with a 
standardized patient.
E-learning
Topics of the e-learning portion were selected by mem-
bers of the KOKON network30 in light of CIM topics 
commonly discussed with patients who have cancer. 
Researchers and clinicians in the field of CIM and oncol-
ogy were asked to coauthor e-learning lessons and were 
supported by an e-learning editor. E-learning lessons cor-
responded to learning objectives following constructive 
alignment rules.31 Lessons, formative assessments, and 
summative assessments (single and multiple-choice for-
mat) were integrated. Texts were reviewed by at least 2 
independent reviewers with experience in the respective 
field. Stakeholders (oncology physicians, medical stu-
dents) reviewed various aspects, such as the structure of 
the modules, the diversity of the learning experiences (eg, 
text, audio, video, infographics), and assessment ques-
tions. Tracking of learning success was used to remind 
participants to complete the e-learning (70% to pass) 
before attending the workshop.
Workshop
The 2-day, on-site skills training workshop aimed to com-
bine knowledge from the e-learning lessons with clinical 
practice. By using diverse didactical methods, such as 
presentations and role-play exercises, oncology physicians 
were trained to follow the manual. At the end of the work-
shop, each oncology physician conducted a KOKON-
KTO consultation with a standardized patient.32 In total, 
4 workshops were performed (2 in March, 1 in November, 
and 1 in December 2018).
Eligibility Criteria for Participants in the 
KOKON-KTO Training
Oncology physicians were eligible if they fulfilled the 
following selection criteria: little knowledge of CIM, 
no previous structured trainings in CIM in the field of 
oncology, minimal experience in advising patients with 
cancer on CIM, ability to take part in the on-site skills 
training workshop, and good German-language skills. 
Participants (50% oncology gynecologists treating 
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malignancies such as breast and ovarian cancer; 50% 
medical oncologists treating other cancer types) were 
recruited from hospital departments and private prac-
tices specialized in oncology as part of an ongoing 
randomized controlled trial.33 In Germany, oncology 
gynecologists are trained in surgical and pharmacologic 
treatment principles for the respective cancer entities. 
The included oncology physicians were either board-
certified oncology residents or were in residency train-
ing treating their own patients with cancer.
Evaluation of KOKON-KTO Training
E-learning
After the e-learning lessons, physicians rated their sat-
isfaction with the training. The web-based assessment 
(SoSci Survey) consisted of 19 items, which were rated 
on a numerical rating scale (NRS) from 1 (strongly disa-
gree) to 4 (strongly agree), and 3 open-ended items. To 
assess whether the learning objectives were reached, situ-
ational judgement tests (SJTs) were presented to 2 train-
ing groups (November and December 2018) before and 
after the e-learning.33 Participants were asked to choose 
the most suitable answer of 5 options for a given CIM-
specific consultation situation. Depending on their spe-
cialization, physicians received either 6 gynecologic SJTs 
(3 breast cancer and 3 ovarian cancer) or 9 nongynecolog-
ical SJTs (3 each of lung, pancreatic, and colon cancer).
Workshop
The workshop was evaluated on 2 levels (physician level 
and physician-patient interaction level). Oncology phy-
sicians completed a paper-and-pencil questionnaire (21 
items rated on an NRS from 1 [strongly disagree] to 4 
[strongly agree]) on their satisfaction. The KOKON-
KTO consultations with standardized patients were rated 
by 2 independent, experienced external raters using a pur-
pose-built questionnaire tailored to the KOKON-KTO 
consultation manual (10 items rated on an NRS from 1 
[strongly disagree] to 10 [strongly agree]). All raters were 
trained for reliability. Interrater reliability was assessed by 
calculating the interclass correlation. If medium-to-high 
agreement was reached, then descriptive statistics were 
applied.
Semistructured, face-to-face interviews were con-
ducted with each standardized patient, who was asked 
about their experience and perception in their role. The 
interviews were audiotaped and transcribed verbatim. A 
qualitative content analysis according to Flick34 was per-
formed and supported by the qualitative data-analysis 
software MAXQDA (VERBI Software).35 The transcripts 
were coded in content units combining deductive and 
 inductive coding strategies. The research team predefined 
deductive codes according to the KOKON-KTO con-
sultation manual. Other subcategories were created in a 
continuous process of inductively building codes from 
the data, and an intersubjective validation of the coding 
by 2 independent researchers was conducted to verify the 
reliability and robustness of the data analysis.
RESULTS
Development of the KOKON-KTO Framework
KOKON-KTO consultation manual
The literature search revealed 8 publications with rel-
evance for the project. One of these articles7 provided 
the main guidance, which included 5 consecutive steps, 
whereas the other publications contributed to the topics 
covered by the manual (Table 1).6-7,14,23,36-40 In the first 
consensus round, relevant aspects of the consultation con-
text, such as the setting and the effect of the physician’s 
attitude, were added.
In the second consensus round, feedback from 
the survey participants (n = 11) resulted in additional 
recommendations on how to tackle challenges, such as 
whether the conversation moved away from the CIM 
topic, and the addition of inform as a first step in the 
manual to communicate general aspects of the con-
sultation. Three survey participants suggested more 
individualization in the consultation step order; 6 par-
ticipants stated that the content of the guideline might 
exceed the time frame. The semistructured interviews 
with 3 patients who had cancer showed overall satisfac-
tion. However, 1 patient would have preferred a longer 
consultation to discuss his previous CIM experience in 
depth.
In the third round, the manual was divided into 3 
sections: section A, providing guidance to the context; 
section B, the steps of the KOKON-KTO consultation 
(inform, capture, prioritize, advise, discuss, concretize ad-
vice), and section C, monitor. The steps capture, prioritize, 
advise, and discuss could now be applied in flexible order, 
allowing adaptation to each physicians’ communication 
style. The final KOKON-KTO consultation manual 
(see Supporting Information) described 8 steps, includ-
ing example phrases and recommendations on how to 
deal with the typical challenges that could occur during 
a KOKON-KTO consultation. To facilitate convenient 
use of the manual, a pocket card (Fig. 2) was developed. 
In addition, a questionnaire to capture patients’ previous 
CIM use was provided as part of the training materials.
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Pilot testing in clinical practice
Three oncology physicians conducted KOKON-KTO 
consultations with 9 patients. The manual seemed to be 
feasible for physicians who had basic CIM knowledge. 
The flexibility of the steps was received positively, and 
small design changes for the pocket card were suggested. 
The physicians agreed that the manual structure met pa-
tients’ needs and highlighted the necessity of informing 
patients from the beginning about the aim of the consul-
tation to set expectations.
The KOKON-KTO training
The e-learning consisted of 9 units (45  minutes each) 
divided into 3 mandatory courses: CIM and cancer (1 
unit), CIM therapies (6 units), and KOKON-KTO con-
sultation (2 units) (see Supporting Table 4).
The workshop consisted of 16 units over 2  days 
(see Supporting Table 4). Because the manual-guided 
KOKON-KTO consultation was developed to be con-
ducted with the oncology physician’s own patients, the 
participants were introduced to 1 case vignette (a female 
patient who had cancer with fatigue) before the work-
shop. All role-play exercises used the same case vignette, 
but the focus or treatment stage was varied according to 
the learning objectives of the lecture.
Evaluation of the KOKON-KTO Training
In total, 47 oncology physicians were recruited (see 
Supporting Table 5). However, only 37 completed the 
e-learning module and its evaluation (see for e-learning 
results, see Fig. 3; for workshop results, see Fig. 4). 
Because oncology physicians were recruited from an 
ongoing randomized controlled trial, physicians from 
the control group33 received the training after the inter-
vention phase (11 months after recruitment). Reasons 
for the dropouts included job change, unavailability 
on the workshop date, and health reasons. Overall, the 
e-learning and the workshop were rated positively, and 
the majority of participants were satisfied with the con-
tent and its presentation. Moreover, the participants 
showed good overall results in the SJTs (average propor-
tion of correct group answers: gynecologic SJTs, 83.3%; 
oncologic SJTs, 77.8%).
The agreement between external raters for the par-
ticipant observation during the KOKON-KTO consulta-
tions with a standardized patient was substantial (average 
interclass correlation, R2 = 0.58 ± 0.29). An analysis of 
the purpose-built rating scale for the role-play exercises 
during the training showed that participants were able 
to demonstrate each of the components specified in the 
KOKON-KTO consultation manual (Table 2) within the 
time frame.
Interviews with standardized patients
Standardized patients in their role felt positive about 
the KOKON-KTO consultation. The timeframe for the 
consultation was found to be appropriate. One stand-
ardized patient thought that even less than 20 minutes 
might be feasible to prevent patients from being over-
loaded with information. They felt enabled to take up 
time to speak or to interrupt the physicians if neces-
sary. However, in some situations, they felt that they 
were not allowed enough time to speak about them-
selves and their complaints (as the standardized patient 
TABLE 1. Structure and Topics of the First Draft of the Manual
Steps Topic Reference(s)
Opening of the consultation Personal greeting Trant 201936
  Setting Schofield 2010,7 Johnston & Beckman 2019,37 
Paladino 2019,38 Foley 2019,39 Ben-Arye & 
Samuels 201940
Understand and respect patients’ perspective General reasons for CIM use Schofield 20107
  Risks of interaction and side effects of CIM Verhoef 20086
  Empathy Verhoef 2008,6 Schofield 20107
Asking about CIM use and reasons why Patients’ interest Verhoef 2008,6 Schofield 2010,7 Lee 201414
  Previous and present CIM use Schofield 2010,7 Lee 201414
Advise and respond Introduction to nutrition Schofield 20107
  Introduction to exercise and relaxation Schofield 20107
  Individual recommendations on CIM Schofield 2010,7 Lee 201414
  Shared decision making Verhoef 2008,6 Schofield 20107
Summarize Summary Schofield 2010,7 Johnston & Beckman 201937
  Development of therapy plan Schofield 2010,7 Lee 201414
  End of consultation and follow-up/documentation Verhoef 2008,6 Schofield 2010,7 Lee 201414
Abbreviation: CIM, complementary and integrative medicine.
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with cancer). The relevant content of the scientific 
information seemed to be understandable to them. 
Nevertheless, they did not always understand the scien-
tific explanation or the meaning of the scientific terms 
(see Supporting Table 6).
Standardized patients especially welcomed individ-
ual, resource-oriented CIM recommendations by the 
physicians. In their opinion, such an approach facilitated 
implementation of the CIM recommendations into daily 
practice.
Implementation strategy
The successful realization of the implementation strat-
egy was reflected in fast recruitment and a waiting list 
for study participation. Of the 37 oncology physicians 
participating in the e-learning module, 100% completed 
and 98% participated in its evaluation. After recruitment, 
physicians had to wait up to 11 months for the workshop; 
still, 77% participated in the workshop. The KOKON-
KTO framework was developed for oncology physicians 
on the assumption that they are often asked about CIM 
Figure 2. Details of the final training content, as presented in a pocket card that can be used during consultations, are shown. An 
asterisk indicates complementary and integrative medicine (CIM). KOKON-KTO indicates Competence Network for Complementary 
Medicine  - Consultation Training for Oncology Physicians.
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by patients with cancer. Given the rapid recruitment of 
study participants (including a waiting list), the assump-
tion can be considered confirmed, and implementation 
of the manual can be considered likely. Timeframe and 
content were implemented as planned and were efficient 
in teaching CIM content (see results for SJTs, above); 
moreover, all physician participants were able to conduct 
a KOKON-KTO consultation at the end of the training. 
Because the consultation was developed to be applied 
during the physicians’ daily workflow, implementation 
Figure 3. Evaluation results (e-learning) are illustrated. Items were scored on a categorical scale ranging from 1 (strongly disagree) 
to 4 (strongly agree).
Figure 4. Evaluation results (workshop) are illustrated. Items were scored on a categorical scale ranging from 1 (strongly disagree) 
to 4 (strongly agree).
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has a low threshold and requires no extra costs for clinics 
or private practices.
DISCUSSION
The project resulted in a blended learning program for 
oncology physicians that uses common standards for 
competencies and learning objectives. The training was 
based on a consultation manual, and criteria defined as 
relevant for broad training implementation were reached. 
The ratings of the KOKON-KTO consultations with 
standardized patients and the SJTs showed that the learn-
ing objectives were fulfilled. However, because this study 
did not assess the participants in their own clinical ac-
tivity, the implementation and fidelity of the KOKON-
KTO consultation manual needs further investigation 
in the ongoing KOKON-KTO study.33 Standardized 
 patients may provide indications but cannot represent 
 patients actually diagnosed with cancer.
As part of the implementation strategy for the 
KOKON-KTO framework, trained oncology physi-
cians continue to provide feedback within the ongoing 
KOKON-KTO study. Applying the KOKON-KTO skills 
in their own clinical environment, oncology physicians 
will provide information on its clinical feasibility (dura-
tion of the consultation and implementation in the daily 
work practice), patient and physician satisfaction with 
the consultation, as well as challenges occurring during 
the KOKON-KTO consultation. Moreover, patients will 
answer questionnaires about their satisfaction, preparation 
for decision making on CIM, physicians’ communication 
skill level, and their CIM use. This will provide results 
both on feasibility and on the quality of communication 
and preparation for decision making. Another aspect that 
must continuously to be monitored is its feasibility (eg,. 
reimbursement, time, change of attitudes toward CIM) 
in health systems.
The KOKON-KTO training, with its evi-
dence-based approach to CIM, fits the needs expressed 
by physicians.17,19,41 The combination of e-learning with 
an on-site workshop was well received, and these results 
were in line with previous findings.17 The evaluation pro-
cess clearly showed that the continuous adaptation of the 
framework was useful. However, the e-learning lessons 
could be adapted more closely to the manual to provide 
a good knowledge foundation for the on-site workshop. 
Furthermore, e-learning could allow more individual 
freedom to deepen CIM knowledge over optional mod-
ules, which might have led to higher satisfaction with the 
learning progress and a reduction in training time.
The on-site workshop included a strong focus on 
communication skills. The physicians’ individual com-
munication style may influence patient satisfaction41; 
moreover, the literature suggests that, especially for phy-
sicians working in oncology, a patient-centered commu-
nication approach may not only enhance shared decision 
making but also may lead to better therapy outcomes.37-39 
TABLE 2. Rating of Consultation With Standardized Patients at the End of the Workshop, With 2 Raters per 
Oncology Physician (Mean ± Standard Deviation Over All Physicians)a
Participant Was Able To:
Rating: Mean ± SD
Gynecology, n = 17 Oncology, n = 20 Total, n = 37
Explain CIM as a supportive therapy (inform) 8.7 ± 2.1 9.1 ± 1.9 8.9 ± 2.0
Record experiences and current CIM use of the patient 
according to the situation (capture)
9.5 ± 1.2 9.9 ± 0.6 9.7 ± 0.9
Set priorities internally or with the patient and  
communicate this process to the patient (prioritize)
8.6 ± 1.4 9.1 ± 1.3 8.9 ± 1.4
Inform about the general potential of movement and 
relaxation in cancer (advise)
9.7 ± 0.8 9.5 ± 1.1 9.6 ± 1.0
Give information on concrete CIM therapies (depending on 
the situation and the patient’s questions)
9.9 ± 0.4 9.7 ± 0.5 9.8 ± 0.5
Advise, accept, or advise against CIM treatment (discuss) 9.5 ± 1.0 9.9 ± 0.4 9.7 ± 0.8
Give concrete recommendations for an implementation 
(concretize)
9.4 ± 0.8 9.2 ± 0.8 9.3 ± 0.8
Consider all steps of the KOKON-KTO consultation 
manual
9.2 ± 0.9 9.1 ± 1.1 9.1 ± 1.0
Always put focus on CIM during conversation 10.0 ± 0.0 9.9 ± 0.4 10.0 ± 0.3
Address the challenge posed by means of a  
recommendation given in the guideline (advise: explain 
reason, offer alternative)
8.4 ± 2.2 9.1 ± 1.4 8.7 ± 1.8
Abbreviations: CIM, complementary and integrative medicine; KOKON-KTO, Competence Network for Complementary Medicine  - Consultation Training for 
Oncology Physicians.
aItems were rated on a numerical rating scale from 1 (strongly disagree) to 10 (strongly agree).
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Concerns that were expressed in the surveys regarding the 
timeframe and a possible lack of individualization were 
not confirmed.
A limitation of the study is that training only 1 
profession of the cancer care team does not reflect the 
multidimensional communication axis that is in place 
in routine care. Oncology care is applied in an inter-
professional context, and this needs to be addressed in 
the future. However, the literature described a clear gap 
between patients’ needs and physicians’ skills, so com-
mencing with oncology physicians (who have early con-
tact with patients during their cancer journey) seemed 
to be the appropriate starting point. Future research 
calls for broadening the KOKON-KTO framework 
to other professions. In addition to interprofessional 
aspects, the future research should also take into 
account intercultural aspects.
Finally, oncology physicians who have received 
KOKON-KTO training cannot replace integrative phy-
sicians, who will have far greater training and in-depth 
knowledge of integrative therapies. The KOKON-KTO 
framework does not train integrative oncology physi-
cians to whom the cancer team can refer for special 
treatment. There are other training programs avail-
able, including some online,40 that focus on those 
competencies.
The KOKON-KTO framework enables oncology 
physicians to provide basic evidence-based advice on CIM 
to their patients with cancer. This may allow an improved 
standard of care by reducing side effects of CAM use and 
improving adherence to cancer treatments.
Conclusion
To the best of our knowledge, the KOKON-KTO 
framework provides a systematically developed, evi-
dence-based and evaluated CIM consultation manual 
and training for oncology physicians. We have demon-
strated that the KOKON-KTO framework is suitable 
for training oncology physicians to give CIM advice 
to their patients with cancer, and its implementation 
could lead to better physician-patient communication 
about the use of CIM.
FUNDING SUPPORT
This project was part of the Competence Network for Complementary 
Medicine in Oncology (KOKON) established as a collaborative research 
project funded by the German Cancer Aid (Deutsche Krebshilfe, grants 
109863 and 70112369) and the Günter und Regine Kelm Stiftung.
CONFLICT OF INTEREST DISCLOSURES
The authors made no disclosures.
AUTHOR CONTRIBUTIONS
Claudia M. Witt: Wrote the article and contributed to the design and con-
duct of the study. Stefanie M. Helmer: Wrote the article and contributed 
to the design and conduct of the study. Marisa Wastell: Contributed to 
the study and revised the article. Penelope Schofield: Contributed to the 
study and revised the article. Anita V. Thomae: Developed the majority of 
the e-learning content. Claudia Canella: Supervised the qualitative analy-
sis. Alizé A. Rogge: Wrote the article and contributed to the design and 
conduct of the study. All authors read and approved the final version of 
the article.
REFERENCES
 1. Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen 
M. How many cancer patients use complementary and alternative 
medicine: a systematic review and metaanalysis. Integr Cancer Ther. 
2012;11(3):187-203.
 2. Vickers KA, Jolly KB, Greenfield SM. Herbal medicine: women’s 
views, knowledge and interaction with doctors: a qualitative study. 
BMC Complement Altern Med. 2006;6:40.
 3. Kessel KA, Lettner S, Kessel C, et al. Use of complementary and alter-
native medicine (CAM) as part of the oncological treatment: survey 
about patients’ attitude towards CAM in a university-based oncology 
center in Germany. PLoS One. 2016;11:e0165801.
 4. Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A. Reasons for 
and characteristics associated with complementary and alternative 
medicine use among adult cancer patients: a systematic review. Integr 
Cancer Ther. 2005;4:274-286.
 5. Johnson SB, Park HS, Gross CP, Yu JB. Complementary medicine, 
 refusal of conventional cancer therapy, and survival among patients 
with curable cancers. JAMA Oncol. 2018;4:1375-1381.
 6. Verhoef MJ, Boon HS, Page SA. Talking to cancer patients about com-
plementary therapies: is it the physician’s responsibility? Curr Oncol. 
2008;15(suppl 2):s88-s93.
 7. Schofield P, Diggens J, Charleson C, Marigliani P, Jeffor M. Effectively 
discussing complementary and alternative medicine in a conventional 
oncology setting. Communication recommendations for clinicians. 
Patient Educ Couns. 2010;79:143-151.
 8. Oskay-Ozcelik G, Lehmacher W, Konsgen D, et al. Breast cancer pa-
tients’ expectations in respect of the physician-patient relationship and 
treatment management results of a survey of 617 patients. Ann Oncol. 
2007;18:479-484.
 9. Arthur K, Belliard JC, Hardin SB, Knecht K, Chen CS, Montgomery 
S. Reasons to use and disclose use of complementary medicine use—an 
insight from cancer patients. Cancer Clin Oncol. 2013;2:81-92.
 10. Roter DL, Yost KJ, O’Byrne T, et al. Communication predictors and 
consequences of complementary and alternative medicine (CAM) dis-
cussions in oncology visits. Patient Educ Couns. 2016;99:1519-1525.
 11. van den Brink-Muinen A, Rijken PM. Does trust in health care influ-
ence the use of complementary and alternative medicine by chronically 
ill people? BMC Public Health. 2006;6:188-188.
 12. Ben-Arye E, Dahan O, Shalom-Sharabi I, Samuels N. Inverse rela-
tionship between reduced fatigue and severity of anemia in oncology 
patients treated with integrative medicine: understanding the paradox. 
Support Care Cancer. 2018;26:4039-4048.
 13. Shalom-Sharabi I, Lavie O, Samuels N, Keinan-Boker L, Lev E, Ben-
Arye E. Can complementary medicine increase adherence to chemo-
therapy dosing protocol? A controlled study in an integrative oncology 
setting. J Cancer Res Clin Oncol. 2017;143:2535-2543.
 14. Lee RT, Barbo A, Lopez G, et al. National survey of US oncologists’ 
knowledge, attitudes, and practice patterns regarding herb and supple-
ment use by patients with cancer. J Clin Oncol. 2014;32:4095-4101.
 15. Witt C. Training oncology physicians to advise their patients on 
complementary and integrative medicine. J Altern Complement Med. 
2018;24(9-10):1016-1017.
 16. Frenkel M. Clinical consultation. A personal perspective: components 
of a successful integrative medicine clinical consultation. J Soc Integr 
Oncol. 2008;6:129-133.
 17. Klein GE, Guethlin C. Information and training needs regarding com-
plementary and alternative medicine: a cross-sectional study of cancer 
care providers in Germany. Integr Cancer Ther. 2018;17:380-387.
KOKON-KTO Training/Witt et al
3041Cancer  July 1, 2020
 18. Munstedt K, Harren H, von Georgi R, Hackethal A. Complementary 
and alternative medicine: comparison of current knowledge, attitudes 
and interest among German medical students and doctors. Evid Based 
Complement Alternat Med. 2011;2011:790951.
 19. Tautz E, Momm F, Hasenburg A, Guethlin C. Use of complementary 
and alternative medicine in breast cancer patients and their experiences: 
a cross-sectional study. Eur J Cancer. 2012;48:3133-3139.
 20. Tasaki K, Maskarinec G, Shumay DM, Tatsumura Y, Kakai H. 
Communication between physicians and cancer patients about com-
plementary and alternative medicine: exploring patients’ perspectives. 
Psychooncology. 2002;11:212-220.
 21. Bauer MS, Kirchner J. Implementation science: what is it and why 
should I care? Psychiatry Res. 2020;283:112376.
 22. Blodt S, Mittring N, Schutzler L, et al. A consultation training program 
for physicians for communication about complementary medicine with 
breast cancer patients: a prospective, multi-center, cluster-randomized, 
mixed-method pilot study. BMC Cancer. 2016;16:843.
 23. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health im-
pact of health promotion interventions: the RE-AIM framework. Am J 
Public Health. 1999;89:1322-1327.
 24. Ben-Arye E, Frenkel M. An approach to teaching physicians about 
complementary medicine in the treatment of cancer. Integr Cancer 
Ther. 2004;3:208-213.
 25. Ben-Arye E, Frenkel M, Bar-Sela G, Margalit RS, Hermoni D, Kuten A. 
Teaching complementary medicine at an academic oncology depart-
ment. J Cancer Educ. 2008;23:46-50.
 26. Leiner DJ. SoSci Survey 2014. Accessed August 8, 2017. https://www.
sosci survey.de/
 27. Anderson LW, Krathwohl DR, Airasian PW, et al. A Taxonomy for 
Learning, Teaching, and Assessing: Pearson New International Edition: 
A Revision of Bloom’s Taxonomy of Educational Objectives, Abridged 
Edition. Pearson New International Edition: Pearson Education 
Limited; 2013.
 28. Society for Integrative Oncology. Society for Integrative Oncology 
website, 2018. Accessed October 11, 2018. https://integ rativ eonc.org/
 29. Moodlerooms. Moodlerooms. 2005. Accessed August 10, 2017. 
https://www.neoco smo.de/black board/
 30. Witt CM, Bartsch HH, Guethlin C, et al. Kompetenznetz 
Komplementrmedizin in der Onkologie (KOKON)—Ein wissen-
schaftlicher Beitrag zur Verbesserung der Versorgung. Forum. 2017;32: 
416-423.
 31. Biggs J, Tang C. Teaching for Quality Learning at University. McGraw-
Hill and Open University Press; 2011.
 32. Charite University of Medicine of Berlin. Simulationspatientenprogramm. 
2018; Accessed October 11, 2018. https://www.chari te.de/studi um_
lehre /struk tur_einri chtun gen/simul ation spati enten progr amm/
 33. Helmer SM, Rogge AA, Fischer F, et al. Evaluation of a blended- 
learning training concept to train oncology physicians to advise their 
 patients about complementary and integrative medicine (KOKON-
KTO): study protocol for a prospective, multi-center, cluster-randomized 
trial. Trials. 2019;20:90.
 34. Flick U. Doing Triangulation and Mixed Methods. Vol 2. Sage 
Publications; 2018.
 35. MAXQDA Analytics Pro [computer program]. VERBI Software; 
2016.
 36. Trant AA, Szekely B, Mougalian SS, et al. The impact of communi-
cation style on patient satisfaction. Breast Cancer Res Treat. 2019; 
176:349-356.
 37. Johnston FM, Beckman M. Navigating difficult conversations. J Surg 
Oncol. 2019;120:23-29.
 38. Paladino J, Bernacki R, Neville BA, et al. Evaluating an intervention to 
improve communication between oncology clinicians and patients with 
life-limiting cancer: a cluster randomized clinical trial of the Serious 
Illness Care Program. JAMA Oncol. 2019;5:801-809.
 39. Foley H, Steel A, Cramer H, Wardle J, Adams J. Disclosure of com-
plementary medicine use to medical providers: a systematic review and 
meta-analysis. Sci Rep. 2019;9:1573.
 40. Ben-Arye E, Samuels N. Traditional herbal medicine in supportive can-
cer care: from alternative to integrative. Accessed October 31, 2019. 
https://www.cours era.org/learn /cance r-medic ine-alter nativ e-herba 
l-asia
 41. Klein E, Beckmann MW, Bader W, et al. Gynecologic oncologists’ atti-
tudes and practices relating to integrative medicine: results of a nation-
wide AGO survey. Arch Gynecol Obstet. 2017;296:295-301.
